11 results
Responsible body
CHMP Remove CHMP filter
-
List item
Press release: European Medicines Agency: Committee for Medicinal Products for Human Use 24-27 July 2006
CHMP, Last updated: 28/07/2006bicalutamide 150 mg … a referral procedure for bicalutamide 150 mg-containing medicinal … following suspension of Casodex (bicalutamide) 150 mg, from AstraZeneca … -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 March 2017
European Medicines Agency, London, UK, from 20/03/2017 to 23/03/2017, Last updated: 20/03/2017 -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,21-24 May 2007
CHMP, Last updated: 25/05/2007the safety and efficacy of bicalutamide 150 mg-containing medicinal … -
List item
Committee for Medicinal Products for Human Use (CHMP): 29 March – 01 April 2016
European Medicines Agency, London, UK, from 29/03/2016 to 01/04/2016, Last updated: 06/01/2014 -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,23-26 April 2007
CHMP, Last updated: 27/04/2007 -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,17-20 September 2007
CHMP, Last updated: 21/09/2007 -
List item
Workshop on site and histology - Independent indications in oncology
European Medicines Agency, London, UK, from 14/12/2017 to 15/12/2017, Last updated: 07/02/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 March 2018
European Medicines Agency, London, UK, from 19/03/2018 to 22/03/2018, Last updated: 31/05/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 17-20 September 2018
European Medicines Agency, London, UK, from 17/09/2018 to 20/09/2018, Last updated: 31/10/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 28-31 May 2018
European Medicines Agency, London, UK, from 28/05/2018 to 31/05/2018, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 July 2018
European Medicines Agency, London, UK, from 23/07/2018 to 26/07/2018, Last updated: 06/01/2014